Search

With more and more Single Nucleotide Polymorphisms (SNPs) being identified throughout the genome, some of those SNPs will be found to be located within candidate genes, allowing the researchers to use the candidate gene approach on a genomewide scale. SNPs have some drawbacks but when compared to other markers they are more efficient and SNP consortium is growing to meet the requirements of genome-wide scans. Genomic selection should be able to at least double the rate of genetic gain in the dairy industry but the incorporation of genomic information into the breeding programs must be carefully considered. One needs to have around 2000 genotypes means a large reference population (population with both phenotype and genotype recorded) to achieve meaningful increases in accuracy. The available information, selection objectives, production circumstances and benefit/cost analysis must be evaluated in order to decide whether or not the population is suitable for GS implementation, and which would be the most convenient way, if any, for its implementation. Animal breeders will need to lead the way on the integration of genomic and phenotypic data into a new era of genome-enabled animal improvement and management. [ABSTRACT FROM AUTHOR]

Anthropozoonotic parasite Toxoplasma gondii causes widespread human and animal diseases, mostly involving central nervous system. Human acquires toxoplasmosis from cats, from consuming raw or undercooked meat and from vertical transmission to the fetus through placenta from mother during pregnancy. Socio-epidemiological as well as unique environmental factors also plays a significant role in transmission of this infection. Preventive measures should be taken into account the importance of culture, tradition, and beliefs of people in various communities more than solving poverty and giving health education. Therefore the focus of this article is to create public awareness regarding sense of responsibility of looking after pets to prevent such an important zoonotic disease. [ABSTRACT FROM AUTHOR]

Nanobiotechnology is an emerging field that is potentially changing the way we treat diseases through drug delivery and tissue engineering. Methods of targeting nanoparticles to specific sites of the body while avoiding capture by vital organs are major hurdles that need to be answered. Whether actual or perceived, the potential health hazards associated with the production, distribution and use of nanomaterial must be balanced by the overall benefit that nanobiotechnology has to offer biomedical science such as therapeutic and diagnostic applications. It would be difficult to deny the potential benefits of nanobiotechnology and stop development of research related to it since it has already begun to penetrate many different fields of research. However, nanobiotechnology can be developed using guidelines to insure that the technology does not become too potentially harmful. As Richard Feynmann has rightly predicted that "There is plenty of room at the bottom" to modify and enhance existing technologies by manipulating material properties at the nanoscale, therefore with sufficient time and research nanobiotechnology based early detection, diagnosis and treatment of various diseases may become a reality. Nanobiotechnology may bring immense paradigm shift that we would wonder that how did we live without it? [ABSTRACT FROM AUTHOR]

Aim: The present study was undertaken to identify whether single nucleotide polymorphism (SNP) rs109231409 located on mannose-binding lectins 1 (MBL1) gene was associated with mastitis tolerance/susceptibility. Materials and Methods: After grouping 100 Vrindavani crossbred cattle as mastitis positive and negative animals, they were genotyped using polymerase chain reaction (PCR)-restriction fragment length polymorphisms method. Gene and genotype frequencies of different patterns were estimated by standard procedure (POPGENE version 1.32, (University of Alberta, Canada) and statistical analysis was carried out by logistic regression methods using STATA 12 software (StataCorp LP, USA). Results: The 588 bp fragment of MBL1 gene was amplified using PCR. PCR product was digested with ApaI restriction enzyme showed two distinct genotypes viz., GG (311 bp and 272 bp fragments) and GA (588 bp, 311 bp and 277 bp fragments). The gene, genotype frequencies, average heterozygosity, polymorphic information content and X2values for the locus rs109231409 was ascertained. Conclusions: No significant association between SNP "rs109231409" with mastitis tolerance was found. Although there is a lack of association, further studies have to be undertaken in a large population in order to validate the impact of rs109231409 (g.855G >A) on mastitis tolerance. [ABSTRACT FROM AUTHOR]